Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west experience

Anti‐viral therapy is associated with improved survival but is underutilised in patients with... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alimentary Pharmacology & Therapeutics Wiley

Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west experience

Download PDF
11 pages

Loading next page...
 
/lp/wiley/anti-viral-therapy-is-associated-with-improved-survival-but-is-hobUFAZklx
Publisher
Wiley
Copyright
Copyright © 2018 John Wiley & Sons Ltd
ISSN
0269-2813
eISSN
1365-2036
DOI
10.1111/apt.14801
Publisher site
See Article on Publisher Site

Abstract

Journal

Alimentary Pharmacology & Therapeutics – Wiley

Published: Jan 1, 2018

References

  • Global Cancer Facts & Figures
  • Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
    Beasley, RP; Lin, C‐C; Hwang, L‐Y; Chien, C‐S
  • Long‐term prognosis after resection of hepatocellular carcinoma associated with hepatitis B‐related cirrhosis
    Poon, RT; Fan, ST; Lo, CM; Liu, CL; Ng, IO; Wong, J
  • Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis
    Kim, JM; Kwon, CH; Joh, JW
  • Prevention of hepatitis B virus‐related hepatocellular carcinoma with antiviral therapy
    Lai, CL; Yuen, MF
  • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    Liaw, Y‐F; Sung, JJY; Chow, WC
  • The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long‐term nucleos(t)ide analogue therapy
    Coffin, CS; Rezaeeaval, M; Pang, JX
  • Antiviral therapy improves post‐hepatectomy survival in patients with hepatitis B virus‐related hepatocellular carcinoma: a prospective‐retrospective study
    Chong, CCN; Wong, GLH; Wong, VWS
  • Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus‐related hepatocellular carcinoma: a two‐stage longitudinal clinical study
    Yin, J; Li, N; Han, Y
  • Meta‐analysis: the efficacy of anti‐viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B‐related hepatocellular carcinoma
    Wong, JS; Wong, GL; Tsoi, KK
  • Association between nucleoside analogues and risk of hepatitis B virus‐related hepatocellular carcinoma recurrence following liver resection
    Wu, C‐Y; Chen, Y‐J; Ho, HJ
  • Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus‐related hepatocellular carcinoma after radiofrequency ablation
    Lee, TY; Lin, JT; Zeng, YS; Chen, YJ; Wu, MS; Wu, CY
  • Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma
    Xu, X; Huang, P; Tian, H
  • Antiviral therapy in the improvement of survival of patients with hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib
    Xu, L; Gao, H; Huang, J
  • A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV‐related HCC treated with sorafenib
    Yang, Y; Wen, F; Li, J
  • AASLD guidelines for treatment of chronic hepatitis B
    Terrault, NA; Bzowej, NH; Chang, KM
  • Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
    Liaw, YF; Kao, JH; Piratvisuth, T
  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
  • Reimbursement policies in the Asia‐Pacific for chronic hepatitis B
    Lim, SG; Amarapurkar, DN; Chan, HL
  • The cascade of care in chronic hepatitis B
    Liou, IW; Nguyen, MH
  • Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics
    Ku, KC; Li, J; Ha, NB; Martin, M; Nguyen, VG; Nguyen, MH
  • Low treatment rates in patients meeting guideline criteria in diverse practice settings
    Kim, LH; Nguyen, VG; Trinh, HN; Li, J; Zhang, JQ; Nguyen, MH
  • Management of hepatocellular carcinoma: an update
    Bruix, J; Sherman, M
  • Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
    Park, JW; Chen, M; Colombo, M
  • National Death Index
  • Asian‐Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
    Sarin, SK; Kumar, M; Lau, GK
  • Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival
    Duffy, SW; Nagtegaal, ID; Wallis, M
  • Improved survival in patients with viral hepatitis‐induced hepatocellular carcinoma undergoing recommended abdominal ultrasound surveillance in Ontario: a population‐based retrospective cohort study
    Thein, H‐H; Campitelli, MA; Yeung, LT; Zaheen, A; Yoshida, EM; Earle, CC
  • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
    Llovet, JM; Real, MI; Montaña, X
  • Sorafenib in advanced hepatocellular carcinoma
    Llovet, JM; Ricci, S; Mazzaferro, V
  • Reduction of chronic hepatitis B‐related hepatocellular carcinoma with anti‐viral therapy, including low risk patients
    Lin, D; Yang, HI; Nguyen, N
  • Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta‐analysis
    Lok, AS; McMahon, BJ; Brown, RS
  • Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States
    Tong, MJ; Hsien, C; Hsu, L; Sun, HE; Blatt, LM
  • Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH‐B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients
    Chen, TM; Chang, CC; Huang, PT; Wen, CF; Lin, CC
  • Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case‐control study of 213 hepatocellular carcinoma patients from India
    Kumar, M; Kumar, R; Hissar, SS
  • Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic area
    Kwak, HW; Park, JW; Nam, BH
  • Long‐term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan
    Chen, CH; Su, WW; Yang, SS
  • Effects of cirrhosis on short‐term and long‐term survival of patients with hepatitis B‐related hepatocellular carcinoma
    Chen, VL; Le, AK; Kim, NG
  • Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma
    Yang, JD; Kim, WR; Coelho, R
  • Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
    Chayanupatkul, M; Omino, R; Mittal, S